Paydirt
CB
Insider

Christoph Brackmann

Chief Financial Officer

Christoph Brackmann (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in NVCR. Across 1 priced purchase filing, the average 21-session return was +1.9% from execution and +4.6% from disclosure (delay-adjusted; derived). The largest single filing was $116K of NVCR (10,000 sh × $11.63, as filed), executed Jul 29 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
+1.9%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+4.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$116K
shares × price, as filed
Last traded
Jul 29 2025
Filed Jul 30 2025
Open performance→
Volume by month
$116K$58K$0Oct 2024Apr 2025Oct 2025Apr 2026Jul 2025 · buys $116K
Buys $116K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 24 months

Most traded names
NVCR NVCR NVCR · 1 buy · 0 sells 1 filing
Recent filings
NVCRPURCHASE NovoCure Ltd View filing → $116K
10,000 sh × $11.63
Exec Jul 29 2025
Filed Jul 30 2025 · 4:33 PM ET